Position
Creative Planning in Neurocrine Biosciences Inc
Back to the book · All holders of NBIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$537.4K$141.83 → $131.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 53.3K | $7.55M | — | — | — | 0.0% |
| Q1 2026 | 68.4K | $9.01M | $131.74 | −$537.4K | $1.99M | 0.0% |